Higher Risk Environment Is A Tailwind For CME Group
I last reviewed CME Group (CME) in this November 14, 2022 post at which time the most recently available financial information was for Q3 and YTD2022. At the time of that post, my CME exposure consisted of 382 CME shares in a 'Core' account and 321 shares in a 'Side' account within the FFJ Portfolio. [...]